Lack of associations of microRNAs with severe NAFLD in people living with HIV: Discovery c

Lack of associations of microRNAs with severe NAFLD in people living with HIV: Discovery c
E-MTAB-12974 · ArrayExpress

TL;DR — A 135.5 KB bulk RNA-seq deposit (E-MTAB-12974, 3 file(s), liver) in the MASLD / NAFLD / NASH data lake. new MASLD bulk-RNAseq deposit.


0. Summary

Biological premise.

The following premise is sourced from the repository record (not fabricated).

The aim of this discovery case-control study was to identify patterns of differential expression of microRNAs in people living with HIV (PLWH) and assess their diagnostic value for non-alcoholic fatty liver disease (NALFD). Cases were defined as patients with severe NAFLD and controls as patients without NAFLD, characterized using the controlled attenuation parameter (CAP). Cases and controls were matched 1:1 for age, sex, body mass index, CD4+ lymphocyte count, active HCV infection, and ART regimen. Serum 2,083 simultaneous microRNA transcripts were analyzed using HTG technology and compared between cases and controls. Forty-five patients, 23 cases, and 22 controls were included in the study. In the analysis of the expression pattern of the 2,083 microRNAs, no differential expression patterns were found between both groups of patients included in the study. Analysis of the microRNA transcriptome profile of nonobese PLWH with severe NAFLD did not appear to differ from that of patients without NAFLD. Thus, microRNA might not serve as a proper biomarker for predicting severe NALFD in this population.

Study design (repository-stated): microRNA profiling by high throughput sequencing

Every file in this dataset is a bulk RNA-seq readout relevant to MASLD / non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), landed from ArrayExpress.

Assay and processing.

Modality: bulk RNA-seq (repository subtype: bulk-RNAseq). Tier-1 (must-have) for this modality = raw/normalized gene × sample expression matrix + per-sample design; Tier-2 (recommended) = author DE tables, design/contrasts, gene annotation; Tier-3 (optional / raw) = raw reads (FASTQ/BAM in SRA/ENA), reference build + quantifier version. The Completeness line in each dataset block below states, measured from the landed files, which tiers are present.

Sources.

  • E-MTAB-12974 — ArrayExpress deposit (new MASLD bulk-RNAseq deposit).
  • PMIDs: none recorded in the index for this deposit.
DiseaseMASLD / NAFLD / NASH
Assay / modalitybulk RNA-seq — bulk-RNAseq
Organismsunspecified
RepositoryArrayExpress — EBI BioStudies
AccessionE-MTAB-12974
AccessPublic (open); files mirrored in this dataset's input/ folder.
Number of studies1
Number of files3
Total size135,494 bytes (≈ 135.5 KB)

1. Datasets — sample sources, protocols, experiment design and metadata

Landed sources at a glance.

SourceAccessFiles
ArrayExpresspublic / OPEN-processed3

The deposit at a glance.

AccessionDescriptionOrganismSamplesScale
E-MTAB-12974new MASLD bulk-RNAseq depositunspecifiedn/a3 files · 135.5 KB

E-MTAB-12974 — Lack of associations of microRNAs with severe NAFLD in people living with HIV: Discovery c

ArrayExpress record · 3 files · 135.5 KB

  • Sample source. unspecified material; MASLD/NAFLD/NASH context (new MASLD bulk-RNAseq deposit).

  • Samples and retention. Sample count not declared in the repository index; see the per-sample metadata file(s) listed below.

  • Experiment design. Repository subtype: bulk-RNAseq; disease context MASLD/NAFLD/NASH.

  • Metadata available. Measured column names from E-MTAB-12974.sdrf.txt: Source Name, Comment[ENA_SAMPLE], Comment[BioSD_SAMPLE], Characteristics[organism], Characteristics[individual], Characteristics[organism part], Characteristics[disease], Material Type, Protocol REF, Performer, Protocol REF, Performer, Protocol REF, Performer, Extract Name, Comment[LIBRARY_LAYOUT], Comment[LIBRARY_SELECTION], Comment[LIBRARY_SOURCE], Comment[LIBRARY_STRAND], Comment[LIBRARY_STRATEGY], Protocol REF, Performer, Assay Name, Comment[technical replicate group], Technology Type ….

  • Files (annotated).

    FileWhat it is
    E-MTAB-12974.idf.txtArrayExpress Investigation Description Format — study design, protocol descriptions, contacts, publication (38 data rows × 2 cols)
    E-MTAB-12974.sdrf.txtArrayExpress Sample-and-Data Relationship Format — per-sample↔run table: characteristics, library geometry, archive/FASTQ links (180 data rows × 32 cols)
    E-MTAB-12974_metadata.docxData file
  • How this experiment became a dataset. E-MTAB-12974 resolved via the ArrayExpress record API → 3 open file(s) fetched into this dataset's input/ folder → sizes verified on disk (135,494 bytes (≈ 135.5 KB)).

  • Completeness (bulk RNA-seq). Present: per-sample design (Tier-1). Not detected among landed files: expression matrix (Tier-1). (Tiers per the matching modality skill; assessment measured from landed filenames/headers.)


2. Analyses this atlas supports

  • Differential expression. Start from E-MTAB-12974.idf.txt (expression matrix) + E-MTAB-12974.sdrf.txt (per-sample design) to run DESeq2/edgeR or limma contrasts and MASLD signatures.
  • Cross-cohort MASLD integration. Combine this deposit (E-MTAB-12974) with other liver/MASLD datasets in the lake sharing the same modality for meta-analysis.

Reproduce. All files are in this dataset's input/ folder; the source of record is E-MTAB-12974 (https://www.ebi.ac.uk/biostudies/studies/E-MTAB-12974). Re-fetch with the MASLD crawler (masld_download_pass.py --only E-MTAB-12974); sizes are verified on disk and recorded in this dataset's metadata.json.


Citation

Lack of associations of microRNAs with severe NAFLD in people living with HIV: Discovery c. ArrayExpress accession E-MTAB-12974. https://www.ebi.ac.uk/biostudies/studies/E-MTAB-12974

About this dataset

This 10x Genomics dataset provides single-cell gene expression from liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.